Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G) (N-Term) Peptide
APOBEC3G
Reactivity: Human
BP
Sodium azide
-
- Target See all APOBEC3G products
- APOBEC3G (Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G))
- Protein Region
- N-Term
- Origin
- Human
- Application
- Blocking Peptide (BP)
- Characteristics
-
15 amino acids near the amino terminus of human APOBEC3G.
Human
-
Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G) peptide
APOBEC3G Reactivity: Human Host: Synthetic BP, Imm
-
- Application Notes
- The peptide is used for blocking the activity of APOBEC3G.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 200 μg/mL
- Buffer
- PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
- Preservative
- Sodium azide
- Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- -20 °C
- Expiry Date
- 12 months
-
- Target
- APOBEC3G (Apolipoprotein B mRNA Editing Enzyme, Catalytic Polypeptide-Like 3G (APOBEC3G))
- Synonyms
- A3G Peptide, ARCD Peptide, ARP-9 Peptide, ARP9 Peptide, CEM-15 Peptide, CEM15 Peptide, bK150C2.7 Peptide, dJ494G10.1 Peptide, apolipoprotein B mRNA editing enzyme catalytic subunit 3G Peptide, APOBEC3G Peptide
-
You are here:
